| 
| Webinar: A Systems Model of Gene Therapy for Sickle Cell Disease Tuesday, November 30 | 2pm ET / 11am PT Stem cell gene therapy is an emerging experimental therapy for SCD with the potential for lifelong cure but it is an expensive multi-step treatment regimen. This webinar is ideal for scientists and decision makers in drug R&D who want to leverage systems pharmacology for drug discovery and development. Register Now. |
Featured Story | By Nick Paul Taylor The poster child of the Spanish biotech scene has secured its exit. Having twice smashed the Spanish biotech financing record in recent years, Sanifit has now accepted a 205 million euro ($231 million) buyout bid from Vifor Pharma. read more |
| |
|---|
|
Top Stories By Ben Adams Neurocrine Biosciences and Sosei Heptares, no strangers to major research pacts, are joining forces for a range of early- to midstage neuro assets. read more By Nick Paul Taylor Xencor has finally found a buyer for its autoimmune disease bispecific antibody obexelimab. Almost three years after deciding to partner the drug in the wake of a failed phase 2, Xencor has offloaded the asset to Zenas BioPharma in a backloaded deal worth up to $480 million. read more Sponsored By: New Product Planning Summit Join us in person on December 1-2 in Boston, MA to become a part of this growing community of eager professionals who are navigating the New Product Planning space during these uncertain times. read more By Ben Adams After deciding not to stick but twist its COVID antibody program last week, Twist Bioscience is now snapping up an antibody drug discovery company. read more By Ben Adams Connect Biopharma connected to the investor community Friday, but not in the way it wanted, as its stock sunk 57% by end of trading on what it touted as positive data for its eczema asset. read more By Conor Hale With a total footprint of about 4 feet by 3 feet, the cobas 5800 comes in a smaller package compared to the company’s high-throughput heavyweights in the cobas 6800 and 8800. read more By Angus Liu Merck & Co. has consumed Acceleron Pharma. Notwithstanding clamorous activist investors, the company has collected enough Acceleron shares to complete the transaction. read more By Robert King The House passed a massive roughly $2 trillion infrastructure bill that includes drug price reforms, closes the Medicaid coverage gap and cuts DSH payments to hospitals in states that did not expand Medicaid. read more Resources Sponsored by: Thermo Fisher Scientific A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants. Sponsored by: IQVIA Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making. Sponsored by: Catalent Biologics Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Blue Matter Consulting Paper describing how the chronic insomnia market offers big lessons for any biopharma company thinking about getting into digital therapeutics in any therapeutic area. Sponsored by: TransPerfect Life Sciences Every detail is important when selecting a new eCOA solution; learn more about the current eCOA landscape, best practices, and crucial considerations for successful eCOA solution deployment in this white paper. Sponsored by: Informa Pharma Intelligence and Oracle Health Sciences New market research provides valuable insight into the impact of adaptations made in clinical trials during the pandemic. Sponsored by: Informa Pharma Intelligence and Oracle Health Sciences Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific Sponsored by: Thermo Fisher Scientific Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Learn how therapeutics are successfully launched and commercialized December 1-2, 2021 | Live & Online Fierce New Product Planning Summit December 1-2, 2021 | Boston, MA Fierce Launch Readiness for Medical Affairs & Communications Teams December 1-2, 2021 | Boston, MA 2nd Annual Symposium on Translational Medicine and Biomanufacturing December 2—3, 2021 Fierce Virtual Clinical Trials Summit December 6-7, 2021 | Philadelphia, PA Fierce JPM Week 2022 January 11, 2022 | San Francisco, CA
January 18-20, 2022 | Virtual Event Virtual European Healthcare Compliance Certificate Program January 24-28, 2022 Fierce Pharma Drug Safety Summit February 8-9, 2022 | Location TBD Fierce Business Development and Licensing Summit March 2022 | San Francisco, CA Fierce Medical Affairs Strategic Summit (MASS) East April 2022 | New Jersey Fierce Health IT Summit April 20, 2022 | Virtual Event Fierce Trial Master File Summit May 2022 | Location TBD Fierce Promotional Review Committee Compliance and Best Practices Summit April 2022 | New Jersey Fierce Digital Pharma Innovation Week June 2022 | Virtual Event Fierce Biotech Next-Gen June 29, 2022 | Virtual Event Fierce Pharma PR & Communications Summit July 2022 | Location TBD (NYC Metro Area) Fierce Biotech Forum October 2022 | Location TBD Fierce Biotech Virtual Forum October 19, 2022 | Virtual Event | 
